Paul Grayson

Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.

Raised $82,500,000.00 from GordonMD Global Investments, 5AM Ventures, Crinetics Pharmaceuticals, DCVC Bio and Frazier Life Sciences.

Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology.

Raised $93,000,000.00 from Gilead Sciences, Amplitude Venture Capital, Versant Ventures and Samsara BioCapital.

Versant Ventures caters to the healthcare sector with early and later stage venture, private equity, and debt financing investments.

Bird Rock Bio is a clinical stage biopharmaceutical company focused on developing innovative immuno-inflammatory regulators.

Raised $77,500,000.00 from Silicon Valley Bank.

Fate Therapeutics is a stem cell and developmental biology research company using biological mechanisms to develop stem cell therapeutics.

Raised $1,340,928,348.00 from Deep Track Capital, Boxer Capital, Suvretta Capital Management, Adage Capital Management and OrbiMed.

Sanderling Ventures is an investment firm that works on building and funding new biomedical companies.